Prognostic value of soluble ST2 in adults with congenital heart disease

OBJECTIVE: Soluble suppression of tumourigenicity-2 (sST2) is upregulated as response to myocardial stress and may be a potential biomarker for risk stratification in patients with adult congenital heart disease (ACHD). This study aimed to investigate the release of sST2 and its association with car...

Descripción completa

Detalles Bibliográficos
Autores principales: Geenen, Laurie W, Baggen, Vivan J M, van den Bosch, Annemien E, Eindhoven, Jannet A, Cuypers, Judith A A E, Witsenburg, Maarten, Boersma, Eric, Roos-Hesselink, Jolien W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Congenital Heart Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582725/
https://www.ncbi.nlm.nih.gov/pubmed/30700520
http://dx.doi.org/10.1136/heartjnl-2018-314168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582725/
https://www.ncbi.nlm.nih.gov/pubmed/30700520
http://dx.doi.org/10.1136/heartjnl-2018-314168

Ejemplares similares